EUCTR2019-002541-37-SE进行中（未招募）1 期
Primary TBE vaccination for the elderly
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •? Adults = 50 år or between 18-40 years
- •? Women and men
- •? Good health
- •? Written consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •? Previous vaccination against TBE
- •? Previous TBE infection
- •? Allergy or hypersensitivity to any substance in the vaccine
- •?Previously known or suspected infection with Japanese encephalitis, Dengue virus, West e fever or Yellow fever
- •? Information on previous vaccination against Yellow fever or Japanese encephalitis
- •? Acute illness, eg fever with malaise
- •? Immunosuppression, due to medication or disease
- •? Previous treatment with Rituximab or equivalent
- •? Autoimmune diseas, including diabetes (diet or tablet-treated diabetes with good metabolic control is accepted, HbA1c < 6 %)
- •? Obesity, BMI > 40
- •? Moderate to severe renal failure including hemodialysis, estimated GFR < 30.
- •? Blood transfusion or immunoglobulins <3 months ago
- •? Pregnancy
- •? Any other illness where the investigator consider the subject unsuitable for the study
- •? The study subject does not want to participate
研究者
相似试验
已完成
不适用
Basic immunization against TBE in persons over fifty years with FSME-IMMUN AdultsProphylaxis of TBE in adult persons over fifty years A84.1A84.1Central European tick-borne encephalitisDRKS00003496Baxter Deutschland GmbH411
进行中（未招募）
不适用
Primary and booster vaccination in old age: Hepatitis A and Hepatitis BThis study will analyze cellular and humoral immune reponses after primary or booster vaccination against HAV and HBV. Healthy adults will be vaccinated with a combination vaccine, which is licensed for all age groups studied in this studyMedDRA version: 16.1Level: LLTClassification code 10054181Term: Hepatitis B immunizationSystem Organ Class: 100000004865MedDRA version: 16.1Level: LLTClassification code 10063436Term: Hepatitis A immunizationSystem Organ Class: 100000004865MedDRA version: 16.1Level: LLTClassification code 10068384Term: Hepatitis immunizationSystem Organ Class: 100000004865EUCTR2013-002589-38-ATniversität Innsbruck, Institut für Biomedizinische Alternsforschung
尚未招募
4 期
Primary TBE Vaccination for the ElderlyVaccineTick-borne EncephalitisNCT04573205Region Örebro County90
进行中（未招募）
不适用
Vaccination against TBE in patients who use immunosuppressive drugsEUCTR2010-019438-28-SEMälarsjukhuset Eskilstuna
招募中
不适用
Improving vaccination uptake among older adults (= 60 years)Vaccination uptake of influenza vaccination in population aged 60 and olderVaccination uptake of further recommended vaccinations for people aged 60 and older: pneumococci, herpes zoster, revaccinations (tetanus, diphtheria and pertussis), COVID-19Vaccine literacyVaccination behaviour and intention Knowledge about influenza and pneumococciDRKS00027252Verband der Ersatzkassen e. V. (vdek), Abteilung Ambulante Versorgung,2,114